Phase 3 FIND trial shows ctDNA-guided surveillance detects recurrence earlier than standard CT scans after curative surgery

▪ SCREENING

The randomized trial found that circulating tumor DNA methylation monitoring identified recurrent metastatic disease with a more favorable and potentially resectable anatomical profile, significantly increasing the proportion of patients who received curative-intent metastasis-directed therapy. (Journal of Clinical Oncology)